Saroglitazar Magnesium 1 mg Clinical Trials
3 recruitingDrug
Phase 12Phase 31
Showing 1–3 of 3 trials
Recruiting
Phase 1
Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease
CirrhosisCholestatic Liver DiseaseHepatic Impairment
Zydus Therapeutics Inc.30 enrolled1 locationNCT05045482
Recruiting
Phase 3
Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis
Primary Biliary Cholangitis
Zydus Therapeutics Inc.150 enrolled28 locationsNCT06427395
Recruiting
Phase 1
Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
Cholestatic Liver Disease
Zydus Therapeutics Inc.6 enrolled1 locationNCT06825559